CERENOME, INC. Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent
CERENOME, INC. (CNSY) had Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent of $500.00 thousand as of 2024-03-08, per its 10-Q filed 2025-10-30.
Financial Statements › Income Statement › Net Income
us-gaap:IncomeLossFromContinuingOperations · last filed 2025-10-30
- 2024-03-08: Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $500.00K.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent |
|---|---|
| 2024-03-08 | $500.00K 10-Q · filed 2025-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |